Evidence map›Paper›PMID 31315569›Full record

ArticleBMC infectious diseases2019

Hepatitis C virus infection status and associated factors among a multi-site sample of people who used illicit drugs in the Amazon region.

Aldemir B Oliveira-Filho, Francisco Junior A Santos, Fabricio Quaresma Silva, Nairis Costa Raiol, Camila Carla S Costa, Juliana Nadia F Piauiense, Luisa Caricio Martins, Yasmin Maria N Cardoso, Jeruza Ferraz F Di Miceli, Rafael Lima Resque and 7 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

Aldemir B Oliveira-FilhoLaboratório de Células e Patógenos, Grupo de Estudo e Pesquisa em Populações Vulneráveis (GEPPOV), Instituto de Estudos Costeiros, Campus de Bragança, Universidade Federal do Pará, Alameda Leandro Ribeiro, s/n. Aldeia, Bragança, PA, Brazil. olivfilho@ufpa.br.ORCID http://orcid.org/0000-0002-4888-3530
Francisco Junior A SantosLaboratório de Células e Patógenos, Grupo de Estudo e Pesquisa em Populações Vulneráveis (GEPPOV), Instituto de Estudos Costeiros, Campus de Bragança, Universidade Federal do Pará, Alameda Leandro Ribeiro, s/n. Aldeia, Bragança, PA, Brazil.
Fabricio Quaresma SilvaLaboratório de Células e Patógenos, Grupo de Estudo e Pesquisa em Populações Vulneráveis (GEPPOV), Instituto de Estudos Costeiros, Campus de Bragança, Universidade Federal do Pará, Alameda Leandro Ribeiro, s/n. Aldeia, Bragança, PA, Brazil.
Nairis Costa RaiolLaboratório de Células e Patógenos, Grupo de Estudo e Pesquisa em Populações Vulneráveis (GEPPOV), Instituto de Estudos Costeiros, Campus de Bragança, Universidade Federal do Pará, Alameda Leandro Ribeiro, s/n. Aldeia, Bragança, PA, Brazil.
Camila Carla S CostaLaboratório de Células e Patógenos, Grupo de Estudo e Pesquisa em Populações Vulneráveis (GEPPOV), Instituto de Estudos Costeiros, Campus de Bragança, Universidade Federal do Pará, Alameda Leandro Ribeiro, s/n. Aldeia, Bragança, PA, Brazil.
Juliana Nadia F PiauienseLaboratório de Células e Patógenos, Grupo de Estudo e Pesquisa em Populações Vulneráveis (GEPPOV), Instituto de Estudos Costeiros, Campus de Bragança, Universidade Federal do Pará, Alameda Leandro Ribeiro, s/n. Aldeia, Bragança, PA, Brazil.
Luisa Caricio MartinsLaboratório de Patologia Clínica de Doenças Tropicais, Núcleo de Medicina Tropical, Universidade Federal do Pará, Belém, PA, Brazil.
Yasmin Maria N CardosoLaboratório de Toxicologia e Química Farmacêutica, Centro de Ciências Biológicas e da Saúde, Universidade Federal do Amapá, Macapá, AP, Brazil.
Jeruza Ferraz F Di MiceliLaboratório de Toxicologia e Química Farmacêutica, Centro de Ciências Biológicas e da Saúde, Universidade Federal do Amapá, Macapá, AP, Brazil.
Rafael Lima ResqueLaboratório de Toxicologia e Química Farmacêutica, Centro de Ciências Biológicas e da Saúde, Universidade Federal do Amapá, Macapá, AP, Brazil.
Gláucia C Silva-OliveiraLaboratório de Células e Patógenos, Grupo de Estudo e Pesquisa em Populações Vulneráveis (GEPPOV), Instituto de Estudos Costeiros, Campus de Bragança, Universidade Federal do Pará, Alameda Leandro Ribeiro, s/n. Aldeia, Bragança, PA, Brazil.
Luiz Marcelo L PinheiroFaculdade de Ciências Biológicas, Campus do Marajó - Soure, Universidade Federal do Pará, Soure, PA, Brazil.
Luiz Fernando A MachadoLaboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, PA, Brazil.
João Renato R PinhoLaboratório de Gastroenterologia e Hepatologia, Instituto de Medicina Tropical, Universidade de São Paulo, São Paulo, SP, Brazil.
José Alexandre R LemosPrograma de Pós-Graduação Profissional em Análises Clínicas, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, PA, Brazil.
Emil KupekDepartamento de Saúde Pública, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil.
Benedikt FischerInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, Canada.
Universidade Federal do Pará · BRUniversidade Federal do Amapá · BRCentre for Addiction and Mental Health · CAUniversidade de São Paulo · BRUniversidade Federal de Santa Catarina · BR

Funding

FAMILIAL COLORECTAL NEOPLASIA COLLABORATIVE GROUPU01CA074800 · NCI · MAYO CLINIC ROCHESTER · PI LINDOR, NORALANE MOREY · 1997 to 2007
$9.1M
The Familial Colorectal Neoplasia Collaborative GroupU24CA074800 · NCI · MAYO CLINIC ROCHESTER · PI LINDOR, NORALANE MOREY, THIBODEAU, STEPHEN NORMAN · 2008 to 2011
$5.3M
HSRD VA CDP 13-003
6 · The paper itself

Abstract

backgroundElevated rates of Hepatitis C Virus (HCV) infection have been reported in epidemiological studies with people who used illicit drugs (PWUIDs) in different Brazilian regions. In Brazil's Amazon region, studies have already identified the common use of illicit drugs among adolescents and the high prevalence of HCV infections among PWUIDs. However, all studies done with PWUIDs were conducted with small samples and within limited geographic coverage. This study determined the prevalence and risk factors for HCV infection in PWUIDs in the Amazon region, northern Brazil, as well as estimating the prevalence and factors associated with the HCV spontaneous clearance (HSC).

methodsThis cross-sectional study accessed 1666 PWUIDs from multiple municipalities of the Amazon region. Socio-demographic, economic, drug use and health-related information were collected through interviews. Blood samples collected were tested for the presence of anti-HCV antibodies and RNA-HCV. HCV genotypes were identified by real-time polymerase chain reaction (PCR). Logistic regressions were run to identify factors independently associated with HCV infection status and HSC.

resultsIn total, 577 (34.6%) featured HCV antibodies, of which 384 (23.1%) had active HCV infection and 193 (11.6%) indicated HSC. Genotypes 1 (80.2%) and 3 (18.8%) were detected. HCV infection status was associated with the length of illicit drug use history, factors related to parenteral and sexual transmission, and factors of socio-economic marginalization leading to potential risk activities for HCV. HSC was associated with the ethnic (including indigenous) background of participants.

conclusionsHigh levels of HCV infection were detected in PWUIDs. Genotype 1 was predominant. Intense use of illicit drugs, unprotected sexual intercourse, high number of sexual partners and social marginalization were associated with all HCV infection. HSC was associated with origin (Amazonian-born) and non-white (e.g., Black or Indigenous) of PWUIDs. These findings emphasize the need for improve HCV prevention and control services and care for PWUIDs in the Brazilian Amazon region.

Indexed as

AdolescentAdultBrazilCross-Sectional StudiesFemaleHepacivirusHepatitis CHepatitis C AntibodiesHumansIllicit DrugsMalePrevalenceReal-Time Polymerase Chain ReactionRisk FactorsSocioeconomic FactorsSubstance-Related DisordersHepatitis C AntibodiesIllicit DrugsAmazonBrazilEpidemiologyHCVPeople who used illicit drugsSpontaneous clearance

Identifiers

PMID31315569
PMCPMC6637600
OpenAlexW2957276395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.